中文 | English
Return
Total: 59 , 1/6
Show Home Prev Next End page: GO
MeSH:(Arsenicals/therapeutic use*)

4.Application and assessment of Chinese arsenic drugs in treating malignant hematopathy in China.

Xiao-mei HU ; Feng LIU ; Rou MA

Chinese journal of integrative medicine 2010;16(4):368-377

5.Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia.

Meijuan SUI ; Zhuo ZHANG ; Jin ZHOU ;

Chinese Medical Journal 2014;127(19):3503-3506

6.Efficacy Analysis of Arsenic Trioxide Combined with All Trans Retinoic Acid for Acute Promyelocytic Leukemia.

Li-Li WANG ; Yong-Qiang REN

Journal of Experimental Hematology 2015;23(5):1292-1295

7.Progression of foundational and clinical studies on use of arsenic trioxide in treatment of lymphoma--review.

Ling-Hao LI ; Hui-Min LI

Journal of Experimental Hematology 2007;15(6):1335-1339

8.The effect of arsenic trioxide on QT interval prolongation during APL therapy.

Jin ZHOU ; Ran MENG ; Xiaoxia LI ; Chengfang LU ; Shengjin FAN ; Baofeng YANG

Chinese Medical Journal 2003;116(11):1764-1766

9.Oral Arsenic-Containing Qinghuang Powder: A Potential Drug for Myelodysplastic Syndromes.

Jing MING ; Wei-Yi LIU ; Hai-Yan XIAO ; Yong-Gang XU ; Rou MA ; Xiao-Mei HU

Chinese journal of integrative medicine 2022;28(8):762-768

10.Realgar (α-As4S4) Treats Myelodysplastic Syndromes through Reducing DNA Hypermethylation.

Miao ZHANG ; Jia-Yi ZHANG ; Ming-Qian SUN ; Peng LU ; Jian-Xun LIU

Chinese journal of integrative medicine 2022;28(3):281-288

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 59 , 1/6 Show Home Prev Next End page: GO